Drug intelligence / Profile preview

clascoterone + clindamycin + benzoyl peroxide

Development stage
Phase 4
Lead developer
COSMO Technologies
Modality
Small Molecules
Administration
Topical
01

Overview

This is a **topical combination treatment** for acne vulgaris that consists of three active components: **clascoterone**, **clindamycin**, and **benzoyl peroxide**. - **Clascoterone** is a topical androgen receptor antagonist that reduces sebum production and inhibits androgen-driven inflammation in the skin. - **Clindamycin** is a topical antibiotic that inhibits bacterial protein synthesis and reduces levels of *Cutibacterium acnes* (the bacteria implicated in acne). - **Benzoyl peroxide** is a topical antimicrobial and keratolytic agent that reduces bacterial load, helps prevent antibiotic resistance, and promotes exfoliation of the skin. This combination is designed to target multiple pathogenic pathways in acne: androgen-driven sebum production, bacterial colonization, inflammation, and follicular hyperkeratinization. No unique brand or code name is currently attributed to this specific three-drug combination; the constituents may be used together as separate products in practice[1][2][3].

Other names
clascoterone + Duacclascoterone + benzoyl peroxide + clindamycin
02

Targets

AR (Adrenergic receptors)Bacterial 50S ribosomal subunitGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on clascoterone + clindamycin + benzoyl peroxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clascoterone + clindamycin + benzoyl peroxide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call